Proportion of subjects exhibiting complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit (EOS).

Change from baseline of the composite score from the Children's Dermatology Life Quality Index (CDLQI) assessment at the EOS visit to measure the quality of life and impact of skin disease in the subset of subjects 4 -16 years of age.

Proportion of subjects exhibiting complete clearance of all treatable molluscum lesions (baseline and new) on the Day 63 visit.

(and 2 more...)

250

All

2 Years and older (Child, Adult, Senior)

NCT03377790

VP-102-101

January 4, 2018

September 21, 2018

October 19, 2018

December 19, 2017

December 19, 2017

Alabama Clinical TherapeuticsBirmingham, Alabama, United States

Southeastern Pediatric AssociatesDothan, Alabama, United States

Study Protocol, Inc.,Boynton Beach, Florida, United States

(and 5 more...)

† Study has passed its completion date and status has not been verified in more than two years.